From: Clinical review: Patency of the circuit in continuous renal replacement therapy
Anticoagulant target | Pro | Con |
---|---|---|
Calculated [citrate] in filter 3–5 mmol/l | Fixed ratio of citrate flow and blood flow | Anticoagulation may not be optimal |
No extra monitoring | ||
Fixed buffer supply to patient | ||
[iCa++] postfilter 0.25–0.35 mmol/l | Optimal anticoagulation | Monitoring of postfilter iCa++ |
Adjustment of citrate flow gives varying buffer supply to patient |